Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2019

Proffered paper session - Thoracic cancers

Longitudinal circulating tumour DNA (ctDNA) monitoring for early detection of disease progression and resistance in advanced NSCLC in FLAURA

Date

22 Nov 2019

Session

Proffered paper session - Thoracic cancers

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Thanyanan Reungwetwattana

Citation

Annals of Oncology (2019) 30 (suppl_9): ix183-ix202. 10.1093/annonc/mdz446

Authors

T. Reungwetwattana1, J.E. Gray2, A. Markovets3, N. Nogami4, J.S. Lee5, B.C. Cho6, B. Chewaskulyong7, M. Majem8, N. Peled9, K. Vishwanathan10, A. Todd11, Y. Rukazenkov12, M. Johnson13, C. Barrett3, J. Chmielecki3, R. Hartmaier3, S.S. Ramalingam14

Author affiliations

  • 1 Division Of Medical Oncology, Department Of Medicine, Faculty Of Medicine, Ramathibodi Hospital, Mahidol University, 10400 - Bangkok/TH
  • 2 Department Of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, 33612 - Tampa/US
  • 3 Translational Medicines, Research And Early Development, Oncology R&d, AstraZeneca, Boston/US
  • 4 Department Of Thoracic Oncology, National Hospital Organization Shikoku Cancer Center, 791-0280 - Matsuyama/JP
  • 5 Department Of Medical Oncology, Seoul National University Bundang Hospital, Seoul/KR
  • 6 Division Of Medical Oncology, Department Of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, 03722 - Seoul/KR
  • 7 Oncology Unit, Department Of Medicine, Chiang Mai University, 50200 - Chiang Mai/TH
  • 8 Department Of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona/ES
  • 9 Soroka Cancer Center, Ben-Gurion University, Beer Sheva/IL
  • 10 Clinical Pharmacology And Safety Science, R&d, AstraZeneca, Boston/US
  • 11 Oncology Biometrics, Oncology R&d, AstraZeneca, Cambridge/GB
  • 12 Oncology R&d, Astrazeneca, Cambridge/GB
  • 13 Quantitative Clinical Pharmacology, Research And Early Development, Oncology R&d, AstraZeneca, Cambridge/GB
  • 14 Winship Cancer Institute, Emory University, 30322 - Atlanta/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.